Radblock TM
Radblock TM, licence 02248172: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- KI Canada Ltd.
- NPN or DIN-HM
- 02248172
- Status
- Active licence
- Licence date
- 15 October 2009
- Revision date
- 5 March 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Poly(sorbate) 80, FD&C Blue No.2, FD&C Yellow No. 5, Dioxyde de titane, FD & C Jaune no. 6, Hydroxypropyl methylcellulose, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Comprimé | Not specified |
| Enfants | minimum: 3.0 Année(s) ; maximum: 18.0 Année(s) | 1.0 Comprimé | Not specified |
| Adultes (enceintes et/ou allaitantes) | Not specified | 2.0 Comprimé | Not specified |
| Enfants | maximum: 1.0 Mois | 0.25 Comprimé | Not specified |
| Enfants | minimum: 1.0 Mois ; maximum: 36.0 Mois | 0.5 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Thyroid blocking agent for use in nuclear emergencies involving the release of radioiodine. This medication is to be used in addition to measures to avoid exposure to radiation such as evacuation, shelter and agricultural and food measure to limit the sale and ingestion of radioiodine contaminated food.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 02248172
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.